Alcosanal
Rectal ointment containing sodium oleate for the treatment of hemorrhoids, anal fissures, and anal eczema
Alcosanal is an over-the-counter rectal ointment containing sodium oleate (110 mg) as its active ingredient. It is used for the temporary symptomatic relief of hemorrhoids (piles), anal fissures, and anal eczema. Alcosanal works by exerting an astringent and decongestant effect on the anal tissue, reducing swelling and relieving itching, burning, and pain. The ointment is applied twice daily and comes with an applicator for ease of use. It is manufactured by Sidefarma S.A. (Portugal) and marketed by Cooper Consumer Health B.V. (Netherlands).
Quick Facts
Key Takeaways
- Alcosanal is an over-the-counter rectal ointment used for temporary relief of hemorrhoids, anal fissures, and anal eczema.
- The active ingredient, sodium oleate (110 mg), acts as an astringent that shrinks swollen anal tissue and relieves itching and pain.
- Apply twice daily (morning and evening) to a clean, dry anal area using the included applicator for best results.
- Side effects are rare but may include mild burning or itching at the application site in up to 1 in 1,000 users.
- Consult a healthcare provider if symptoms do not improve, or if you are pregnant, breastfeeding, or allergic to any ingredients.
What Is Alcosanal and What Is It Used For?
Alcosanal is a topical rectal preparation that has been used for decades in European countries for the symptomatic relief of common anorectal conditions. Its active ingredient, sodium oleate, is a salt of oleic acid — a naturally occurring fatty acid found in olive oil, animal fats, and various plant-based oils. When applied to the anal mucosa, sodium oleate produces a distinct astringent action that causes contraction and tightening of the local tissue, thereby reducing the engorgement and swelling characteristic of hemorrhoidal disease.
Hemorrhoids, also known as piles, are swollen and inflamed blood vessels in the rectum and anus that can cause significant discomfort. They affect an estimated 50% of adults over the age of 50 at some point in their lives, according to data from the World Gastroenterology Organisation (WGO). Hemorrhoids are broadly classified into two types: internal hemorrhoids, which develop inside the rectum, and external hemorrhoids, which form under the skin around the anus. Alcosanal is primarily designed to treat symptoms associated with both types when applied topically to the external anal area or just inside the anal canal using the included applicator.
Beyond hemorrhoids, Alcosanal is also indicated for the treatment of anal fissures — small tears in the thin, moist tissue (mucosa) lining the anus — which can cause sharp pain and minor bleeding during bowel movements. Anal fissures are common and often occur as a result of passing hard or large stools, chronic constipation, or straining during defecation. By reducing local swelling and irritation, Alcosanal helps create an environment conducive to tissue healing.
The third primary indication for Alcosanal is anal eczema (perianal dermatitis), a condition characterised by itching, redness, and irritation of the skin surrounding the anus. Anal eczema may be triggered by a variety of factors including excessive moisture, contact irritants (such as soaps or fragrances), allergic reactions, or underlying dermatological conditions. Alcosanal provides symptomatic relief by soothing the irritated tissue and reducing the inflammatory response.
As an over-the-counter (OTC) medication, Alcosanal can be purchased without a prescription from pharmacies across European markets. However, it is important to understand that Alcosanal is intended for temporary symptomatic relief only. If symptoms persist beyond a few days of treatment, or if there is rectal bleeding, significant pain, or other concerning symptoms, patients should seek medical evaluation to rule out more serious anorectal conditions. A healthcare provider may also prescribe Alcosanal for other indications at their clinical discretion.
What Should You Know Before Using Alcosanal?
Before using any medication, it is essential to be aware of contraindications, warnings, and special precautions. While Alcosanal is generally well-tolerated as an over-the-counter product, certain groups of patients should exercise caution or consult a healthcare professional prior to use. The following subsections outline the key considerations.
Contraindications
You should not use Alcosanal if you have a known allergy (hypersensitivity) to sodium oleate or any of the other ingredients contained in the product. The inactive ingredients include Oxynex LM and 5-chlorocarvacrol (a preservative), wool fat (lanolin), liquid paraffin, oleyl oleate, glycerol, and purified water. Lanolin (wool fat) is a known potential allergen, and individuals with a documented sensitivity to lanolin-containing products should exercise particular caution.
If you have previously experienced an allergic reaction to any topical rectal preparation, you should consult your doctor or pharmacist before using Alcosanal. Allergic reactions to rectal preparations, while uncommon, may manifest as increased itching, redness, swelling, or the development of a rash at or near the application site. In the unlikely event of a severe allergic reaction (anaphylaxis), seek emergency medical attention immediately.
Warnings and Precautions
Speak with your doctor or pharmacist before using Alcosanal if you have any pre-existing anorectal conditions that have not been evaluated by a healthcare professional. Rectal bleeding, in particular, should always be investigated by a qualified clinician, as it may be a sign of conditions other than hemorrhoids, including colorectal polyps or, in rare cases, colorectal cancer.
Alcosanal is intended for short-term use only. If your symptoms do not improve within 7 days of regular use, or if they worsen at any point during treatment, discontinue the product and consult a healthcare provider. Prolonged use of rectal preparations without medical supervision is not recommended, as it may mask symptoms of underlying conditions that require different treatment.
The product should be used for external and internal perianal application only. Avoid contact with the eyes. If accidental contact occurs, rinse thoroughly with clean water. Keep the product out of the reach of children. If a child accidentally ingests the product, contact a poison control centre or healthcare provider immediately for risk assessment and guidance.
Pregnancy and Breastfeeding
If you are pregnant, breastfeeding, think you may be pregnant, or are planning to become pregnant, you should consult your doctor or pharmacist before using Alcosanal. Hemorrhoids are particularly common during pregnancy, especially in the third trimester and the immediate postpartum period, due to increased pressure on the pelvic blood vessels. While there are no specific studies on the use of sodium oleate rectal ointment during pregnancy, the topical nature of the product means systemic absorption is expected to be minimal.
Nevertheless, as with all medications during pregnancy and breastfeeding, the potential benefits should be weighed against any potential risks by a healthcare professional. Many healthcare providers may recommend conservative non-pharmacological measures first, such as increasing dietary fibre intake, maintaining adequate hydration, and using sitz baths, before initiating any topical treatment.
Driving and Operating Machinery
Alcosanal ointment does not affect alertness, reaction time, or cognitive function. There are no restrictions on driving or operating machinery while using this product. The active ingredient, sodium oleate, acts locally on the anal tissue and is not absorbed systemically in quantities that would affect the central nervous system.
How Does Alcosanal Interact with Other Drugs?
One of the advantages of topical rectal preparations such as Alcosanal is their localised mechanism of action. Because sodium oleate exerts its effects directly on the anal mucosa and is not absorbed into the systemic circulation in meaningful quantities, the potential for drug-drug interactions is extremely low. No formal interaction studies have been conducted with Alcosanal, and no clinically significant interactions with other medicines have been reported in post-marketing surveillance.
However, there are some practical considerations to keep in mind when using Alcosanal alongside other treatments:
| Medication Type | Interaction Risk | Recommendation |
|---|---|---|
| Other rectal preparations (e.g., corticosteroid suppositories) | Low — potential reduced efficacy | Avoid simultaneous application; space out by at least 30 minutes |
| Oral laxatives and stool softeners | None known | Safe to use together; may complement hemorrhoid management |
| Oral analgesics (paracetamol, ibuprofen) | None known | Safe to use concurrently for additional pain relief |
| Anticoagulants (warfarin, heparin) | None known | No dose adjustment needed; monitor for rectal bleeding as usual |
| Topical anaesthetics (lidocaine-based products) | Low — potential altered absorption | Space out application by 15–30 minutes to ensure full efficacy of each product |
If you are using any other rectal preparations concurrently, it is advisable to space out applications by at least 15 to 30 minutes. Applying multiple products simultaneously to the same area can potentially reduce the efficacy of each preparation, alter absorption characteristics, or increase the risk of local irritation. When in doubt, consult your pharmacist or doctor for advice on the optimal sequence and timing of multiple anorectal treatments.
Patients currently taking immunosuppressive medications or those with compromised immune function should discuss the use of any topical product with their healthcare provider, as wound healing in the anorectal area may be impaired. Although Alcosanal itself does not affect immune function, understanding the full clinical picture is important for comprehensive care.
What Is the Correct Dosage of Alcosanal?
Always use Alcosanal exactly as described in the patient information leaflet or as directed by your doctor or pharmacist. If you are unsure about any aspect of the application, seek advice from a healthcare professional. Correct application technique is important for maximising the therapeutic benefit of the product.
Adults
Standard Adult Dosage
Apply Alcosanal ointment twice daily (morning and evening). Clean and thoroughly dry the anal area before each application. Warm the tube in your hands before use to make the ointment easier to dispense.
For external application, squeeze a small amount of ointment onto a clean fingertip or directly onto the affected area and gently spread it over the irritated skin surrounding the anus. For internal application, attach the included applicator by screwing it onto the tube opening. Gently insert the applicator into the anal canal and slowly squeeze the tube to deposit the ointment. Remove the applicator carefully and clean it after each use.
The duration of treatment should be determined by the severity and persistence of symptoms. For most patients, improvement is noticeable within 3 to 7 days of regular use. If no improvement is observed after 7 days, or if symptoms worsen at any point, discontinue use and consult a healthcare provider for further evaluation.
Children
Paediatric Use
The safety and efficacy of Alcosanal in children has not been specifically established. Anorectal conditions in children are relatively uncommon. Use in children should only be on the advice of a healthcare provider.
Hemorrhoids and related anorectal conditions are uncommon in the paediatric population. If a child experiences perianal symptoms, it is important to seek medical evaluation rather than self-treating with over-the-counter products. A healthcare provider can determine the underlying cause and recommend appropriate treatment, which may or may not include a topical preparation such as Alcosanal.
Elderly
Elderly Patients
No dose adjustment is required for elderly patients. Apply as directed for adults: twice daily, morning and evening. Elderly patients should be particularly vigilant about reporting persistent rectal bleeding or changes in bowel habits to their healthcare provider.
Hemorrhoids are especially prevalent among older adults, and many elderly patients manage their symptoms effectively with topical over-the-counter preparations like Alcosanal. However, because the risk of colorectal pathology increases with age, any new onset of rectal bleeding, changes in bowel habits, or unexplained weight loss in elderly patients warrants prompt medical investigation.
Missed Dose
If you forget to apply Alcosanal at the scheduled time, apply it as soon as you remember. However, if it is almost time for your next application, skip the missed dose and continue with your regular schedule. Do not apply a double dose to make up for a missed application. Consistent twice-daily application provides the best symptomatic relief.
Overdose
If an excessive amount of ointment is applied, or if the product is accidentally ingested (e.g., by a child), contact your local poison control centre or healthcare provider immediately for risk assessment and advice. In most countries, poison control can be reached through emergency services. Take the product packaging with you when seeking medical attention.
Topical overdose with Alcosanal is unlikely to cause systemic adverse effects due to the localised nature of the product. However, applying excessive amounts may increase the risk of local irritation. Accidental oral ingestion, while not expected to cause serious toxicity, should be reported to a healthcare professional as a precautionary measure, particularly if it involves a child.
What Are the Side Effects of Alcosanal?
Like all medicines, Alcosanal can cause side effects, although not everybody gets them. The overall safety profile of Alcosanal is favourable, which is consistent with its longstanding use as an over-the-counter product. The majority of users do not experience any adverse effects. When side effects do occur, they are typically mild and self-limiting, resolving spontaneously upon discontinuation of the product.
The following side effect frequency classification follows the conventions established by the European Medicines Agency (EMA) and the Council for International Organizations of Medical Sciences (CIOMS):
Very Common
May affect more than 1 in 10 people
- No very common side effects have been reported
Common
May affect up to 1 in 10 people
- No common side effects have been reported
Uncommon
May affect up to 1 in 100 people
- No uncommon side effects have been reported
Rare
May affect up to 1 in 1,000 people
- Burning sensation at the application site
- Itching (pruritus) at the application site
The rare occurrence of local burning or itching is typically transient and tends to diminish with continued use or upon discontinuation of the product. These local reactions are generally attributable to the astringent action of sodium oleate on already irritated or broken skin, rather than a true allergic response.
In very rare instances, an allergic contact dermatitis may develop, particularly in individuals with a pre-existing sensitivity to one of the product’s excipients, such as wool fat (lanolin). Symptoms of an allergic reaction may include intensified itching, redness, swelling, or the appearance of a skin rash that extends beyond the application site. If you suspect an allergic reaction, discontinue use immediately and consult a healthcare professional.
Reporting Side Effects
It is important to report suspected side effects after a medicine has been authorised. This allows continuous monitoring of the medicine’s benefit-risk balance. Healthcare professionals and patients are encouraged to report any suspected adverse reactions to their national pharmacovigilance authority. In the European Union, reports can be submitted through the national reporting systems of each member state, which feed into the EudraVigilance database maintained by the European Medicines Agency (EMA).
In the United Kingdom, adverse reactions can be reported via the Yellow Card Scheme operated by the Medicines and Healthcare products Regulatory Agency (MHRA). In the United States, the FDA MedWatch programme accepts voluntary reports of adverse events. Reporting helps ensure that safety information for medicines remains up to date and comprehensive.
How Should You Store Alcosanal?
Proper storage of medications is essential to maintain their effectiveness and safety throughout their shelf life. Alcosanal should be stored in accordance with the following guidelines:
- Keep out of sight and reach of children: Store the product in a secure location where children cannot access it. Accidental ingestion by children, while unlikely to cause serious harm, should be avoided.
- Check the expiry date: Do not use Alcosanal after the expiry date stated on the carton (marked “EXP”). The expiry date refers to the last day of the specified month. Using expired medications may result in reduced efficacy.
- Storage temperature: Store at room temperature. Avoid exposure to excessive heat, direct sunlight, or freezing temperatures, as these may alter the consistency and properties of the ointment.
- After opening: Once opened, the tube should be used within the recommended timeframe as indicated on the packaging. Always replace the cap securely after each use to prevent contamination and drying of the ointment.
- Clean the applicator: After each use, detach the applicator from the tube and clean it with warm water and mild soap. Allow it to dry completely before reattaching or storing.
Safe Disposal
Medicines should not be disposed of via wastewater or household waste, as pharmaceutical compounds can enter waterways and soil, potentially affecting ecosystems. Instead, return any unused or expired Alcosanal to your local pharmacy for safe disposal through an approved pharmaceutical waste programme. Many countries operate take-back schemes at pharmacies specifically designed for this purpose. By disposing of medicines responsibly, you contribute to the protection of the environment.
What Does Alcosanal Contain?
Understanding the full composition of any medication is important, particularly for individuals with known allergies or sensitivities. Alcosanal is a topical rectal ointment with a relatively simple formulation designed to provide effective symptom relief while maintaining stability and a suitable consistency for application.
| Ingredient | Type | Function |
|---|---|---|
| Sodium oleate 110 mg | Active ingredient | Astringent and decongestant action on anal tissue |
| Oxynex LM | Excipient (antioxidant) | Prevents oxidative degradation and extends shelf life |
| 5-Chlorocarvacrol | Preservative | Antimicrobial preservative; prevents microbial contamination |
| Wool fat (lanolin) | Excipient (emollient) | Provides moisture barrier and skin-softening properties |
| Liquid paraffin | Excipient (base) | Ointment base; provides smooth spreadability |
| Oleyl oleate | Excipient (emollient) | Skin-conditioning agent; improves texture and absorption |
| Glycerol | Excipient (humectant) | Retains moisture; prevents drying of the ointment |
| Purified water | Excipient (solvent) | Vehicle for dissolution of active and inactive ingredients |
Appearance and Packaging
Alcosanal ointment is a yellowish-white, odourless semi-solid preparation with a smooth, homogeneous texture. It is supplied in aluminium tubes available in two sizes: 20 g and 50 g. Each tube comes packaged in a cardboard carton together with an applicator (rectal tip) for ease of internal application, as well as a patient information leaflet.
The aluminium tube construction provides effective protection against light, moisture, and air exposure, helping to maintain the stability and potency of the active ingredient throughout the product’s shelf life. The screw-on applicator is designed for single-patient use and should be cleaned after each application to maintain hygiene.
Important Allergen Information
Patients with a known allergy to lanolin (wool fat) should be aware that Alcosanal contains this ingredient. Lanolin sensitivity affects a small percentage of the population and is more common in individuals with pre-existing eczema or contact dermatitis. If you have experienced skin reactions to wool-containing products, cosmetics, or other preparations containing lanolin in the past, discuss this with your pharmacist or doctor before using Alcosanal.
Additionally, 5-chlorocarvacrol, used as a preservative in the formulation, is a chlorinated derivative of carvacrol (a compound found naturally in oregano and thyme oils). While allergic reactions to this preservative are extremely rare, patients with known sensitivities to phenolic compounds should exercise caution.
Frequently Asked Questions About Alcosanal
Medical References
All medical information on this page is based on international guidelines, peer-reviewed research, and official product documentation. Evidence level: Grade 1A.
- European Medicines Agency (EMA). Guidelines on the Summary of Product Characteristics (SmPC) for topical rectal preparations. EMA/CHMP/QWP, 2023.
- World Gastroenterology Organisation (WGO). WGO Practice Guideline — Hemorrhoids. World Gastroenterology Organisation, 2023. Available at: worldgastroenterology.org
- Lohsiriwat V. Hemorrhoids: From basic pathophysiology to clinical management. World Journal of Gastroenterology. 2012;18(17):2009-2017. doi:10.3748/wjg.v18.i17.2009
- Perera N, Liolitsa D, Iype S, et al. Phlebotonics for haemorrhoids. Cochrane Database of Systematic Reviews. 2012;(8):CD004322. doi:10.1002/14651858.CD004322.pub3
- British National Formulary (BNF). Rectal and anal disorders — topical preparations. National Institute for Health and Care Excellence (NICE), 2024. Available at: bnf.nice.org.uk
- World Health Organization (WHO). WHO Model List of Essential Medicines, 23rd list. WHO, 2023.
- Davis BR, Lee-Kong SA, Migaly J, Feingold DL, Steele SR. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Hemorrhoids. Diseases of the Colon & Rectum. 2018;61(3):284-292.
- Altomare DF, Giuratrabocchetta S. Conservative and surgical treatment of haemorrhoids. Nature Reviews Gastroenterology & Hepatology. 2013;10(9):513-521.
- Cooper Consumer Health B.V. Alcosanal Product Information Leaflet (PIL). September 2025.
Medical Editorial Team
Content Authors
Licensed physicians and pharmacologists specialised in gastroenterology, proctology, and clinical pharmacology with extensive clinical experience.
Medical Review
Independent review panel that verifies all content against international medical guidelines and current research.
Qualifications and Credentials
- Licensed specialist physicians with international specialist competence
- Pharmacologists with expertise in rectal preparations and topical drug delivery
- Documented research background with publications in peer-reviewed journals
- Continuous education according to WHO, EMA, and international medical guidelines
- Follows the GRADE framework for evidence-based medicine
Transparency: Our team works according to strict editorial standards and follows international guidelines for medical information. All content undergoes multiple peer review before publication.
iMedic Editorial Standards
Peer Review Process
All medical content is reviewed by at least two licensed specialist physicians before publication.
Fact-Checking
All medical claims are verified against peer-reviewed sources and international guidelines.
Update Frequency
Content is reviewed and updated at least every 12 months or when new research emerges.
Corrections Policy
Any errors are corrected immediately with transparent changelog. Read more
Medical Editorial Board: iMedic has an independent medical editorial board consisting of specialist physicians in gastroenterology, proctology, pharmacology, and general practice.